Analgesic Efficacy of Ultrasound-guided Transverse-abdominal Plain Blockade in Urological Surgery
- Conditions
- Postoperative Pain
- Interventions
- Procedure: Postoperative transverse abdominal plain (TAP) blockade
- Registration Number
- NCT01501565
- Lead Sponsor
- Fundacio Puigvert
- Brief Summary
The purpose of this study is to compare pain level (according to numerical score)at 4, 8, 12 and 24 postoperative hours between patients under transverse abdominal plain blockade (TAP) and patients under conventional analgesia. Also the opioid consumption is assessed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 141
- > 18 yrs.
- Patients undergo laparoscopic urologic surgery
- Physical status ASA < 3
- Surgical procedure without complications
- Signed informed consent
- Allergy to bupivacaine chlorhydrate
- Patients with chronic pain treatment
- Alcoholism
- Decompensated hepatic disease
- Coagulation disorders
- BMI > 35
- Patient involved in another clinical trial
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description TAP Postoperative transverse abdominal plain (TAP) blockade Transverse abdominal plain (TAP) blockade with local anesthetic: Bupivacaine chlorhydrate 0.25% adjusted by weight and type of surgery. Maximum dose: 150 mg of bupivacaine. Two approaches are done: 1)Posterior TAP: the needle insertion point is cephalad to the iliac crest, behind the midaxillary line. The needle is inserted under ultrasound guidance in plane. Local anesthetics is deposited between the internal oblique and transversus abdominis muscles, 2)Subcostal TAP: the needle is inserted ultrasound guided perpendicularly to abdominal wall, directed parallel to the costal margin but oblique to the sagittal plane. Local anesthestic is deposited between transversus abdominis and the rectus abdominis muscles.
- Primary Outcome Measures
Name Time Method Pain level Change in pain from admittance to 24 hours postoperatively Pain is assessed by numerical scale (0 to 10) where 0 is no pain and 10 is the most intense pain possible. Pain will be assessed at 4, 6 , 8, 12 and 24 hours.
- Secondary Outcome Measures
Name Time Method Analgesic consumption as a rescue therapy within 24 postoperative hours Analgesic consumption: morphine in miligrams.
Incidence of postoperative nausea and vomiting (PONV) related to therapy within 24 postoperative hours Assessment of PONV incidence and antiemetic drugs consumption.
Incidence of urethral/bladder spasm within 24 postoperative hours Pain due to bladder catheter.
Assessment of oral intake tolerance within 24 postoperative hours Assessment at 6 postoperative hours for liquids, and solid food at 24 postoperative hours.
Patient satisfaction within 24 postoperative hours Assessed by ordinal scale: Very pleased/Pleased/little pleased/little unpleased/unpleased/very unpleased
Trial Locations
- Locations (1)
Fundació Puigvert
🇪🇸Barcelona, Spain